These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1206031)

  • 1. A plaque assay for the study of influenza virus inhibitors.
    Appleyard G; Maber HB
    J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):49-53. PubMed ID: 1206031
    [No Abstract]   [Full Text] [Related]  

  • 2. Plaque inhibition assay for drug susceptibility testing of influenza viruses.
    Hayden FG; Cote KM; Douglas RG
    Antimicrob Agents Chemother; 1980 May; 17(5):865-70. PubMed ID: 7396473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-n-trifluoracetylneuraminic acid (FANA).
    Schulman JL; Palese P
    Virology; 1975 Jan; 63(1):98-104. PubMed ID: 1167433
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-influenza virus activity of Myrica rubra leaf ethanol extract evaluated using Madino-Darby canine kidney (MDCK) cells.
    Mochida K
    Biosci Biotechnol Biochem; 2008 Nov; 72(11):3018-20. PubMed ID: 18997411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.
    Sidwell RW; Wong MH; Bailey KW; Barnard DL; Jackson MK; Smee DF
    Antivir Chem Chemother; 2001 Nov; 12(6):359-65. PubMed ID: 12018681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
    Oxford JS
    J Antimicrob Chemother; 1975 Mar; 1(1):7-23. PubMed ID: 1100585
    [No Abstract]   [Full Text] [Related]  

  • 7. Ching-fang-pai-tu-san inhibits the release of influenza virus.
    Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
    J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A colorimetric LDH assay for the titration of infectivity and the evaluation of anti-viral activity against ortho- and paramyxoviruses.
    Mori S; Watanabe W; Shigeta S
    Tohoku J Exp Med; 1995 Dec; 177(4):315-25. PubMed ID: 8928191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro.
    Wray SK; Gilbert BE; Knight V
    Antiviral Res; 1985 Feb; 5(1):39-48. PubMed ID: 3985607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative comet infection assay for influenza virus.
    Lindsay SM; Timm A; Yin J
    J Virol Methods; 2012 Feb; 179(2):351-8. PubMed ID: 22155578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change in the sensitivity of influenza virus, replicating in the presence of rimantadine, to antiviral agents].
    Boreko EI; Pavlova NI; Votiakov VI
    Vopr Virusol; 1999; 44(3):115-9. PubMed ID: 10392434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque formation by influenza viruses in the presence of trypsin.
    Appleyard G; Maber HB
    J Gen Virol; 1974 Dec; 25(3):351-7. PubMed ID: 4475092
    [No Abstract]   [Full Text] [Related]  

  • 13. BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses.
    Shih SR; Horng JT; Poon LL; Chen TC; Yeh JY; Hsieh HP; Tseng SN; Chiang C; Li WL; Chao YS; Hsu JT
    J Antimicrob Chemother; 2010 Jan; 65(1):63-71. PubMed ID: 19892833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.
    Macdonald SJ; Watson KG; Cameron R; Chalmers DK; Demaine DA; Fenton RJ; Gower D; Hamblin JN; Hamilton S; Hart GJ; Inglis GG; Jin B; Jones HT; McConnell DB; Mason AM; Nguyen V; Owens IJ; Parry N; Reece PA; Shanahan SE; Smith D; Wu WY; Tucker SP
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4542-9. PubMed ID: 15561823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids).
    Serkedjieva J; Manolova N; Bankova V
    J Nat Prod; 1992 Mar; 55(3):294-302. PubMed ID: 1593279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin.
    Murphy MF
    J Infect Dis; 1978 Aug; 138(2):249-51. PubMed ID: 79625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple plaque assay for influenza A 2 viruses and its application to antiviral screening.
    Bentley J; Wickham EA
    Arch Gesamte Virusforsch; 1971; 33(3):234-41. PubMed ID: 5000191
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of pyrophosphate analogues on influenza virus RNA polymerase and influenza virus multiplication.
    Stridh S; Helgstrand E; Lannerö B; Misiorny A; Stening G; Oberg B
    Arch Virol; 1979; 61(3):245-50. PubMed ID: 227345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The dynamics of multiplication of influenza-virus A-2 in mouse lungs under the influence of 1-aminoadamantan preparations].
    Benda R; Rehn F; Dostálová J
    Zentralbl Bakteriol Orig; 1969 Jul; 210(3):298-303. PubMed ID: 5358861
    [No Abstract]   [Full Text] [Related]  

  • 20. [New research on recombination in orthomyxoviruses (author's transl)].
    Podchermiaeva RAa ; Sokolov MI
    Vopr Virusol; 1975; (5):515-20. PubMed ID: 1108449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.